Steven E. Nissen, MD, lead author of the study “Bempedoic Acid And Cardiovascular Outcomes In Statin-Intolerant Patients,” answers questions on the importance of his team’s research on bempedoic acid, how...
In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...
In this Q&A, Jordana B. Cohen, MD, MSCE, assistant professor of medicine and epidemiology at the University of Pennsylvania School of Medicine, and a nephrologist and research scientist at the...
Passive smoking exposure is known to cause adverse health outcomes, but what is the association between passive smoking exposure and the risk of hypertension? In this Q&A, Onoja Apka, PhD, answered...
How do patterns of blood pressure change over the life course and differ between men and women? A new analysis contradicts what you think you know. Lead researcher Susan Cheng, MD, MPH, MMSc, offers her...
Luke Joseph Laffin, MD, from the Cleveland Clinic Foundation, answers our questions about his research on the effect of phase 2 cardiac rehabilitation on exercise capacity and outcomes in patients with...
Andres Pineda Maldonado, MD, from the University of Florida, Jacksonville, answers our questions about new therapies for mitral valve disease, the different recommendations for men vs women, and more.
What are the associations between Takotsubo syndrome and cannabis use? In this Q&A, Rupak Desai, MBBS, explains what he and his research team discovered about the relationship and how their results...
James J. Matera, DO, explains the importance of treating hyperkalemia – a common occurrence in patients with chronic kidney disease – in the context of comorbid cardiometabolic disease.
The medical community is uniquely positioned to help combat the spread of medical misinformation. Now that online groups opposed to proven medical interventions are taking aim at statins, here is what...
